Enhancement of solubility and antidiabetic effects of Repaglinide using spray drying technique in STZ-induced diabetic rats

(2017) Enhancement of solubility and antidiabetic effects of Repaglinide using spray drying technique in STZ-induced diabetic rats. Pharmaceutical Development and Technology. pp. 754-763. ISSN 1083-7450

Full text not available from this repository.

Abstract

The purpose of the study was to enhance the solubility of the poorly water-soluble drug, Repaglinide using spray drying based solid dispersion technique by different carriers including Eudragit E100, hydroxyl propyl cellulose Mw 80000 and poly vinyl pyrollidone K30. Optimization of the best formulation was carried out according to drug solubility, release profile, particle size and angle of repose of the solid dispersions. The optimized sample was characterized using X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC) and Fourier transform infrared spectroscopy (FT-IR). The morphology of the dispersions was studied by SEM. The blood glucose lowering effect of spray dried solid dispersions was studied in normal and streptozocin-induced diabetic rats. The results showed that Eudragit E100 in 1:3 ratio could enhance drug solubility by 100-fold. DSC studies indicated a marked change in melting point of the drug possibly due to strong hydrogen bonds between the drug and Eudragit, while FT-IR study did not show obvious interactions between them. According to XRPD results Repaglinide converted to an amorphous state in the spray dried dispersions. Spray dried Repaglinide reduced the blood glucose level significantly during the 8h of obtaining blood samples in comparison with untreated drug (p<0.05).

Item Type: Article
Keywords: diabetic rats eudragit e100 repaglinide solid dispersion spray drying water-soluble drugs solid dispersions dissolution rate bioavailability cyclodextrin release pellets polymer
Divisions: Novel Drug Delivery Systems Research Center
Faculty of Pharmacy and Pharmaceutical Sciences > Department of Pharmacotherapy
Faculty of Pharmacy and Pharmaceutical Sciences > Department of Toxicology and Pharmacology
Page Range: pp. 754-763
Journal or Publication Title: Pharmaceutical Development and Technology
Journal Index: ISI
Volume: 22
Number: 6
Identification Number: https://doi.org/10.3109/10837450.2016.1143001
ISSN: 1083-7450
Depositing User: مهندس مهدی شریفی
URI: http://eprints.mui.ac.ir/id/eprint/982

Actions (login required)

View Item View Item